tirzepatide mash Key milestones of in the treatment of diabetes, obesity and Eli Lilly's tirzepatide shows promise

Their link to GBD is controversial as GLP1 inhibits gallbladder motility and delays gallbladder emptying

Gastric emptying Semaglutide caused a minor delay of early postprandial gastric emptying, thereby reducing the rate at which glucose appears in the circulation postprandially Body weight and constitution Greater weight loss was observed with semaglutide compared to other studied comparators (placebo, sitagliptin, extended release exenatide, dulaglutide and insulin glargine) (see Clinical Efficacy and Safety)

Dungo R, Deeks ED

But if a patient taking these drugs experiences vision loss, they should call their internist about possibly adjusting the dosage or stopping the medication

In a study in subjects with different degrees of hepatic impairment, no clinically relevant change in semaglutide pharmacokinetics (PK) was observed [see CLINICAL PHARMACOLOGY ]

With the same active ingredient tirzepatide they work the same way in your body and can have the same impact on your health